Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MJT.0000000000001590 | DOI Listing |
Curr Opin Anaesthesiol
August 2023
Department of Anesthesiology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Purpose Of Review: This review describes recent prospective and retrospective work exploring the incidence and clinical consequence of sugammadex-induced bradycardia and an update of recent evidence and adverse event reports to the United States Food and Drug Administration regarding the incidence of sugammadex induced bradycardia.
Recent Findings: This work suggests that the incidence of sugammadex-induced bradycardia can range from 1 to 7% depending on the definition to reverse moderate to deep neuromuscular blockade. For most instances, the bradycardia is inconsequential.
Medicine (Baltimore)
July 2021
Department of Anesthesiology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Rationale: There is evidence that sugammadex can facilitate extubation post-surgery and attenuate postoperative pulmonary complications resulting from postoperative residual neuromuscular blockade. However, it may induce adverse effects, including bronchospasm, laryngospasm, bradycardia, hypotension, and cardiac arrest. Here, we present a case of sugammadex-induced bradycardia and hypotension.
View Article and Find Full Text PDFJA Clin Rep
May 2020
Department of Cardiology, University of Patras Medical School, Queen Olgas Square, 7 Aratou Street, 26221, Patras, Greece.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!